###begin article-title 0
IL-1beta, IL-6, and RANTES as Biomarkers of Chikungunya Severity
###end article-title 0
###begin p 1
Conceived and designed the experiments: LFPN AC YSL. Performed the experiments: YJS DJCK FD KHC ZH. Analyzed the data: LFPN AC DJCK LCN EEO KHC ZH. Contributed reagents/materials/analysis tools: LFPN AC PLL FD YSL. Wrote the paper: LFPN AC DJCK KHC PK YSL.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 48 65 <span type="species:ncbi:37124">Chikungunya virus</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
Little is known about the immunopathogenesis of Chikungunya virus. Circulating levels of immune mediators and growth factors were analyzed from patients infected during the first Singaporean Chikungunya fever outbreak in early 2008 to establish biomarkers associated with infection and/or disease severity.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 583 591 <span type="species:ncbi:9606">patients</span>
Adult patients with laboratory-confirmed Chikungunya fever infection, who were referred to the Communicable Disease Centre/Tan Tock Seng Hospital during the period from January to February 2008, were included in this retrospective study. Plasma fractions were analyzed using a multiplex-microbead immunoassay. Among the patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%) and conjunctivitis (40%). Profiles of 30 cytokines, chemokines, and growth factors were able to discriminate the clinical forms of Chikungunya from healthy controls, with patients classified as non-severe and severe disease. Levels of 8 plasma cytokines and 4 growth factors were significantly elevated. Statistical analysis showed that an increase in IL-1beta, IL-6 and a decrease in RANTES were associated with disease severity.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 115 132 <span type="species:ncbi:37124">Chikungunya virus</span>
###xml 297 305 <span type="species:ncbi:9606">patients</span>
This is the first comprehensive report on the production of cytokines, chemokines, and growth factors during acute Chikungunya virus infection. Using these biomarkers, we were able to distinguish between mild disease and more severe forms of Chikungunya fever, thus enabling the identification of patients with poor prognosis and monitoring of the disease.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 478 481 478 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Enserink1">[1]</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-AbuBakar1">[5]</xref>
###xml 680 683 680 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Borgherini1">[6]</xref>
###xml 684 687 684 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 849 852 849 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Borgherini1">[6]</xref>
###xml 854 857 854 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 1119 1123 1119 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Schuffenecker1">[10]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Chevillon1">[15]</xref>
###xml 1031 1036 <span type="species:ncbi:9606">human</span>
In the recent years, emerging and re-emerging tropical infectious diseases have been shown to cause high social and economic impact. Vector-borne infectious diseases such as Dengue, West Nile have been resurging largely due to the spread of insecticide resistance, to socio-demographic changes, and to genetic mutations in the pathogens. More recently, chikungungya fever (CHIKF) has now emerged as the next important infection in South-East Asia, the Pacific region and Europe [1]-[5], making it a major threat that requires immediate attention. Recent epidemic resurgence of CHIKF in several African and Asian countries demonstrated that infection can spread alarmingly rapidly [6]-[9] from limited early transmission that then developed into an unprecedented and unexpected epidemic, infecting 38% of the population as occurred in Reunion island [6], [8]. The appearance of cases in Europe, the United States and other countries by travelers returning from known outbreak areas underscores the contributory factors of increased human mobility, tourism, global climate change, and increases in insecticide resistance [10]-[15]. In this era of globalization, the threat of such disease epidemics should not be underestimated as such public health events could cripple public health systems and economies.
###end p 9
###begin p 10
###xml 71 82 71 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Togaviridae</italic>
###xml 447 450 447 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 452 455 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 481 486 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aedes</italic>
###xml 506 519 506 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. albopictus</italic>
###xml 524 534 524 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. aegypti</italic>
###xml 0 17 <span type="species:ncbi:37124">Chikungunya virus</span>
###xml 506 519 <span type="species:ncbi:7160">A. albopictus</span>
###xml 524 534 <span type="species:ncbi:7159">A. aegypti</span>
Chikungunya virus (CHIKV), which causes CHIKF, is an alphavirus of the Togaviridae family, with a 12,000-nucleotides linear, positive-sense, single-stranded RNA genome containing two large open reading frames (ORF). The first, ORF1, encodes 4 non-structural proteins (nsP1, nsP2, nsP3 and nsP4) while ORF2 encodes structural proteins that include 1 capsid protein (C), 2 major envelope surface glycoproteins (E1, E2) and 2 small proteins (E3, 6K) [8], [9]. CHIKV is transmitted by Aedes mosquitoes (mainly A. albopictus and A. aegypti).
###end p 10
###begin p 11
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 225 228 225 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Charrel1">[13]</xref>
###xml 516 520 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Toivanen1">[16]</xref>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Taubitz1">[18]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Couderc1">[19]</xref>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ziegler1">[20]</xref>
###xml 935 938 935 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 848 855 <span type="species:ncbi:9606">patient</span>
CHIKF is an acute illness with abrupt fever, skin rash, arthralgia, and occasional involvement of the nervous system, heart and liver. Prolonged incapacitating arthralgia has sometimes been reported to persist for years [8], [9], [13]. It is of concern that the re-emerged CHIKV has caused considerable morbidity and some fatalities, whereas previously CHIKF was considered as relatively benign. Despite the fact that the clinical features of recent acute CHIKV infections from several countries have been described [16]-[18], little is known about the long-term sequelae or the pathogenesis of arthropathy, and the acquisition of protective immunity remains unexplored. It has been proposed that CHIKV-induced arthritis or arthralgia is of immunopathologic origin [19], [20]. At present, there is no specific or effective treatment for CHIKF, and patient management is largely symptomatic relief and primarily anti-inflammatory drugs [8]. Given the expanding geographic range of CHIKV and its potential to rapidly cause large scale epidemics, it has become important to understand the immune and pathogenic mechanisms active during CHIKV infections in order to guide the development of targeted and effective control and treatment strategies.
###end p 11
###begin p 12
###xml 174 178 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee1">[21]</xref>
###xml 481 485 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee1">[21]</xref>
###xml 616 620 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ministry1">[22]</xref>
###xml 622 626 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ministry2">[23]</xref>
###xml 561 569 <span type="species:ncbi:9606">patients</span>
Cytokines and chemokines are thought to play an important role in viral immunopathology. Although IL-2. IL-10 and IFN-gamma have been implicated in the pathogenesis of CHIKF [21], a global analysis of their specific involvement with disease severity has not yet been defined. Growth factors are usually produced in response to injury. Viral infections such as CHIKV, induce cellular damage which may lead to secretion of these factors; however, limited studies have been conducted [21]. In this study, we took the opportunity to conduct a detailed study on the patients from the first outbreak of CHIKF in Singapore [22], [23]. We measured circulating levels of a wide range of cytokines, chemokines, and growth factors in 10 laboratory confirmed cases of CHIKF, and compared them with healthy individuals. We next determined which biomarker was associated with infection and/or severity. We showed for the first time that CHIKV infection induced a wide range of cytokines, chemokines, and growth factors. We subsequently found that 3 specific biomarkers, namely IL-1beta, IL-6, and RANTES levels, were associated with severe CHIKF.
###end p 12
###begin title 13
Results
###end title 13
###begin p 14
###xml 315 316 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 363 367 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Bone1">[24]</xref>
###xml 368 372 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-AIRD1">[28]</xref>
###xml 708 709 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 866 873 860 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004261-t001">Table 1</xref>
###xml 7 15 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 721 729 <span type="species:ncbi:9606">patients</span>
###xml 839 847 <span type="species:ncbi:9606">patients</span>
All 10 patients included in this study were males. Their age ranged from 22 to 65 years (median, 35 years). All except one were foreign nationals. Half of our patients were classified as severe CHIKF. We defined severe CHIKF as having a temperature of >38.5degreesC or pulse rate >100/min, or platelet count <100x109 g/L based on studies defining severe diseases [24]-[28]. Except for the Singapore resident, none had any pre-existing medical condition. Despite being previously healthy, four non-residents developed severe illness. Fever lasted 2-10 days, and fever duration was not significantly different between those who had more severe illness and those who had not (mean, 6.6 days vs. mean, 3.8 days; P>0.05). Two patients reported persistent arthralgia lasting more than two weeks. Demographic and clinical details of the 10 CHIKF patients are summarized in Table 1.
###end p 14
###begin title 15
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Demographic and epidemiologic data on 10 patients with PCR-confirmed chikungunya infection.
###end title 15
###begin p 16
Severity was defined as having a temperature >38.5degreesC or pulse rate >100/min or platelet count <100x10wedge9/L.
###end p 16
###begin p 17
Clinical outcome at 2 weeks post-illness onset.
###end p 17
###begin p 18
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004261-t002">Table 2</xref>
###xml 10 18 <span type="species:ncbi:9606">patients</span>
###xml 240 247 <span type="species:ncbi:9606">patient</span>
Among our patients, the most common clinical features were fever (100%), arthralgia (90%), rash (50%), and conjunctivitis (40%) (Table 2). Gastrointestinal and constitutional symptoms were less prominent. Arthritis was observed in only one patient, who had an effusion on the right knee. None had neurologic involvement or hemorrhagic manifestation.
###end p 18
###begin title 19
Clinical features.
###end title 19
###begin p 20
Nausea, vomiting, diarrhoea, or abdominal pain.
###end p 20
###begin p 21
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004261-t003">Table 3</xref>
###xml 308 309 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 388 389 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 689 690 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1396 1405 1376 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&#8202;=&#8202;0.047</italic>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 322 329 <span type="species:ncbi:9606">patient</span>
###xml 504 512 <span type="species:ncbi:9606">patients</span>
###xml 895 902 <span type="species:ncbi:9606">patient</span>
###xml 954 962 <span type="species:ncbi:9606">patients</span>
###xml 1040 1048 <span type="species:ncbi:9606">patients</span>
###xml 1321 1329 <span type="species:ncbi:9606">patients</span>
Table 3 presents a summary of the key laboratory findings among our patients throughout the course of their illness. White cell count, hemoglobin, hematocrit, platelet count, erythrocyte sedimentation rate for most patients were within the normal range. The mean nadir platelet count (+/-SD) was 199+/-115x109/L. Only one patient had severe thrombocytopenia (nadir platelet count, <100x109/L) during the course of his illness. Elevated C-reactive protein levels (CRP, >10.0 mg/L) were observed in 60% of patients, but the peak C-reactive protein level was not significantly different between those who classified as severely ill and those who were not (mean, 40.3 mg/L vs. mean, 9.9 mg/L; P = 0.195). The mean peak alanine and aspartate transaminases (ALT and AST) (+/-SD) were 58+/-36 U/L and 50+/-25 U/L respectively. Both ALT and AST were 2-fold greater than the upper limit of normal in one patient, who had pre-existing liver cirrhosis. None of the patients had a clinically abnormal total protein, urea or creatinine level. Among our patients, the mean nadir protein level (+/-SD) was 67+/-5 g/dL, and the mean peak urea and creatinine levels (+/-SD) were 5.1+/-1.7 mmol/L and 101+/-16 mmol/L respectively. Lactate dehydrogenase level was the only laboratory parameter that was significantly higher in severely ill patients, compared to those who were not (mean, 732 U/L vs. mean, 525 U/L; P = 0.047).
###end p 21
###begin title 22
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Laboratory parameters in chikungunya confirmed patients.
###end title 22
###begin p 23
###xml 439 447 439 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g001">Figure 1</xref>
###xml 803 812 799 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g002">Figure 2a</xref>
###xml 865 871 861 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;0.05</italic>
###xml 1137 1143 1133 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P&lt;0.05</italic>
###xml 1485 1494 1469 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004261.s001">Figure S1</xref>
###xml 585 593 <span type="species:ncbi:9606">patients</span>
###xml 823 831 <span type="species:ncbi:9606">patients</span>
###xml 1031 1039 <span type="species:ncbi:9606">patients</span>
###xml 1127 1135 <span type="species:ncbi:9606">patients</span>
###xml 1224 1232 <span type="species:ncbi:9606">patients</span>
###xml 1283 1291 <span type="species:ncbi:9606">patients</span>
Profiles of 30 cytokines, chemokines and growth factors were determined by a multiplex-microbead immunoassay on acute blood samples collected upon hospitalization. The samples collected ranged from day 2 to day 19 of illness (median, day 4.5). To characterize the overall patterns, a two-way hierarchical clustering analysis was done to allow the classification of individuals according to disease severity based on the clinical features (Figure 1). Evidently, this had the power to discriminate the clinical forms of CHIKF in the samples in this study from the healthy controls, with patients classified as non-severe and severe disease segregating perfectly. The levels of 8 plasma cytokines (IL-2R, IL-5, IL-6, IL-7, IL-8, IL-10, IL-15 and IFN-alpha) were observed to be most significantly elevated (Figure 2a) in CHIKF patients compared to uninfected subjects (P<0.05). Among these was proinflammatory cytokine, IL-6 which was very significant. Interestingly, another proinflammatory cytokine, IL-8 was down-regulated in these patients. Anti-inflammatory cytokine, IL-10 was found to be significantly raised in most of the patients (P<0.05). The plasma concentrations of IL-2R and IL-5 were found to be increased in all patients. Levels of IFNalpha and IL-7 were elevated in all patients. The levels of other cytokines such as IL-2, IL-4, IL-12, IL-13, IL-17, IFN-gamma, and TNF-alpha, were only marginally increased in the CHIKF group compared with those in the uninfected group (Figure S1).
###end p 23
###begin title 24
Two-way hierarchical clustering analysis.
###end title 24
###begin p 25
Each cell in the 2-dimensional graph indicates the measure of a single mediator in 1 sample, with standardized levels indicated by color according to the scale on the top. Sample clustering resulting from the algorithm described is shown at the right side of the graph, with an indication of the group to which each individual sample belongs. Mediator clustering is depicted on the top of the graph, and detailed at the bottom.
###end p 25
###begin title 26
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Differences in plasma mediator levels in CHIKF patients and healthy controls.
###end title 26
###begin p 27
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&lt;0.05</italic>
a. Levels of cytokines (pg/ml) were determined as described and only those with a P value of <0.05 are illustrated. Horizontal bars indicate the respective groupwise medians. b. Levels of chemokines (pg/ml) were determined. c. Levels of growth factors (pg/ml) were determined.
###end p 27
###begin p 28
###xml 109 118 109 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g002">Figure 2b</xref>
###xml 228 237 221 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004261.s001">Figure S1</xref>
Profiles of chemokines, IP-10 and MIG were shown to be significantly elevated, while Eotaxin was suppressed (Figure 2b). There was no difference in the levels of other chemokines namely, MCP-1, MIP-1alpha, MIP-1beta and RANTES (Figure S1).
###end p 28
###begin p 29
###xml 202 211 202 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g002">Figure 2c</xref>
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004261.s001">Figure S1</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
Interestingly, the levels of 4 growth factors were found to be significant in the patients, with up-regulation of HGF, FGF-basic and VEGF, with the exception of EGF which was almost totally suppressed (Figure 2c). It was observed that the CHIKF patients exhibited low levels of GM-CSF and G-CSF (Figure S1).
###end p 29
###begin p 30
###xml 360 369 357 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g003">Figure 3a</xref>
###xml 438 447 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004261.s002">Figure S2</xref>
###xml 452 454 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004261.s003">S3</xref>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
Finally, in an effort to identify cytokine, chemokine, and growth factor plasmatic levels associated with severity, statistical analyses were performed after stratification of the CHIKF patients according to severity. It was observed that an increase in levels of IL-1beta and IL-6, and a decrease in RANTES respectively were associated with disease severity (Figure 3a). The levels of all other markers were not significantly different (Figure S2 and S3).
###end p 30
###begin title 31
Differences in cytokines, chemokines and growth factors levels determine disease severity.
###end title 31
###begin p 32
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
a. Box-and-whisker plots illustrating the significant differences of IL-1beta, IL-6 and RANTES in patients with non-severe and severe CHIKF. b. Diagrammatic representation of the mediator profiles in CHIKV-infected patients and healthy control subjects, and the distinction between non-severe and severe CHIKF.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ministry1">[22]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ministry1">[22]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Bone1">[24]</xref>
###xml 138 146 <span type="species:ncbi:9606">patients</span>
###xml 263 269 <span type="species:ncbi:9606">people</span>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
CHIKF, an emerging arboviral infection, which induces high fever, has only been recently reported in Singapore. Up to Dec 2007, all CHIKF patients had contracted the infection overseas [22]. The first local outbreak of CHIKF occurred in Jan 2008. More than 2,500 people who lived or worked in the outbreak area were screened and a total of 13 PCR-confirmed cases were identified [22], [24]. All confirmed CHIKF cases were referred to the CDC/TTSH. Our report included 10 patients who participated in this study.
###end p 34
###begin p 35
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-ProMEDmail1">[29]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Charrel1">[13]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Rezza1">[30]</xref>
###xml 739 742 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Borgherini1">[6]</xref>
###xml 743 746 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 748 752 748 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Parola1">[11]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Dash1">[14]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Toivanen1">[16]</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Taubitz1">[18]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee1">[21]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Rezza1">[30]</xref>
###xml 1054 1057 1052 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Borgherini1">[6]</xref>
###xml 1355 1359 1353 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Gerardin1">[31]</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
###xml 807 813 <span type="species:ncbi:9606">people</span>
###xml 881 887 <span type="species:ncbi:9606">people</span>
###xml 940 948 <span type="species:ncbi:9606">patients</span>
###xml 1005 1013 <span type="species:ncbi:9606">patients</span>
###xml 1069 1077 <span type="species:ncbi:9606">patients</span>
###xml 1165 1173 <span type="species:ncbi:9606">patients</span>
###xml 1227 1235 <span type="species:ncbi:9606">patients</span>
Phylogenetic analysis of the viral sequences of our patients has revealed that the circulating strains were of the Indian Ocean genotype and closely related to those from the 2006 outbreak in India [29] but without the A226V mutation, further emphasizing how remarkably rapid the disease could spread with the right environmental conditions. The attack rate in our outbreak was 0.5%, much lower than the 34% reported in Reunion Island and the 5.4% observed in Italy [13], [30]. This could be attributed to the rapid removal of human reservoirs through isolation, enhanced vector control, or the circulation of a virus strain of lower epidemic potential. Clinical features of our patients were similar to those reported in recent outbreaks [6]-[9], [11]-[14], [16]-[18], [21], [30], indicating that although people are genetically diverse response to diseases is homogeneous across people in non-homogeneous populations. The majority of our patients was </=45 years and had no pre-morbid condition. Unlike patients reported in the Reunion Island outbreak [6], where the patients' underlying medical conditions could have contributed to the observed morbidities, our patients were younger and healthier. Furthermore, none of our patients was co-infected with dengue, as confirmed by RT-PCR and dengue enzyme-linked immunoabsorbent assay (ELISA)-IgM and IgG [31]. Hence, our immunologic observations can be largely attributed to acute CHIKV infection itself.
###end p 35
###begin p 36
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Leelarasamee1">[4]</xref>
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Parola1">[11]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Economopoulou1">[17]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Taubitz1">[18]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee1">[21]</xref>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Powers1">[9]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Schuffenecker1">[10]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Couderc1">[19]</xref>
###xml 218 221 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Schuffenecker1">[10]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Bone1">[24]</xref>
###xml 294 299 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aedes</italic>
###xml 299 302 299 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Enserink1">[1]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Beltrane1">[3]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Parola1">[11]</xref>
###xml 313 317 313 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Chevillon1">[15]</xref>
###xml 784 792 776 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 792 796 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Sourisseau1">[32]</xref>
###xml 934 937 922 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 939 943 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Parola1">[11]</xref>
###xml 1033 1037 1017 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Liu1">[33]</xref>
###xml 1052 1056 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Hansmann1">[34]</xref>
In recent years, most of the studies on CHIKF have been addressed with the clinical description of the disease [4]-[9], [11], [17], [18], [21], the molecular nature of the virus [9], [10], [19] and diagnostics methods [8]-[10], [24], and the interactions of the virus with its mosquito vector, Aedes[1]-[3], [11]-[15]. Here, we describe for the first time the comprehensive systemic production of cytokines, chemokines, and growth factors during acute CHIKV infection which may light the path ahead in understanding the innate response to the infection. We first showed that a wide range of cytokines such as IFN-alpha, IL-5, IL-6, IL-7, IL-10, IL-15 were produced in response to CHIKV infection. IFN-alpha is a potent anti-viral cytokine and has been shown to strongly inhibit CHIKV in vitro[32]. The high levels of IFN-alpha that we detected provide a logical explanation for how the body rapidly brings CHIKV viremia under control [8], [11]. It has been shown that the main producers of IFN-alpha are plasmocytoid dendritic cells [33] and monocytes [34].
###end p 36
###begin p 37
###xml 493 496 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 893 897 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Qin1">[35]</xref>
###xml 1169 1172 1161 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-AbuBakar1">[5]</xref>
The profile of circulating cytokines revealed a predominance of Type 2 cytokines. Mainly IL-5, IL-6 and IL-10 levels were increased and those of IFN-gamma or TNF-alpha were unchanged as compared to non-infected controls. This suggests that acute CHIKV infection tilts the cytokine profile to anti-inflammatory response, which would argue against the common understanding of CHIKV infection which does not really support the common description of the CHIKV infection as an inflammatory disease [8]. Alternatively, it is possible that an inflammatory response might occur earlier when the virus is actively replicating, and then gets down-regulated by a counter-anti-inflammatory response when the virus is being eliminated from circulation. High levels of anti-inflammatory IL-10 and the presence of high levels of chemokines IP-10 and MIG (ligands of CXCR3 associated with Th1-type reactions) [35], detected here would support this hypothesis. Further studies would be needed to clarify this issue. The Type 2 cytokines detected are also important mediators of B cell growth and maturation, and thus may allow the production of high levels of persisting anti-CHIKV IgG [5].
###end p 37
###begin p 38
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Carson1">[36]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Giri1">[37]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Rubin1">[38]</xref>
###xml 573 581 <span type="species:ncbi:9606">patients</span>
The detection of high levels of circulating IL-15 is of interest, since this cytokine has been shown to be a major stimulator of NK cells [36] and T cells [37]. Thus our data suggest that these lymphocytes population might be activated during acute infection and may also contribute to viral control during the acute phase of CHIKV infection. Detection of soluble IL-2R in the plasma suggests T cell activation since this molecule is secreted by activated T cells [38]. Experiments are planned to study the activation phenotype of T and NK cell subsets in acutely infected patients.
###end p 38
###begin p 39
###xml 198 201 198 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Borgherini1">[6]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Churchman1">[39]</xref>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Asquith1">[40]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Dalbeth1">[41]</xref>
###xml 970 974 966 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Feldmann1">[42]</xref>
###xml 221 229 <span type="species:ncbi:9606">patients</span>
###xml 712 720 <span type="species:ncbi:9606">patients</span>
###xml 833 841 <span type="species:ncbi:9606">patients</span>
The detection of IL-7 and IL-15 is significantly interesting with regards to the immunopathology of CHIKF since CHIKV infection has been shown to induce rapidly developing and persisting arthralgia [6]. Here, 9 of the 10 patients manifested this pathology. IL-7 is known to have an important role in the development of rheumatoid arthritis [39], while IL-15 has been associated with the development of joint inflammation [40]. It has been proposed that expansion of a particular IL15-induced NK cell subsets was responsible for this phenomenon [41]. The role of IL-15 and NK cells in the development of CHIKV arthralgia would definitively be worth investigating. We did not detect TNF-alpha in the plasma of the patients with acute CHIKV infection. This is surprising since this cytokine has been detected repeatedly in the blood of patients suffering from other arthritides such as rheumatoid arthritis and is known to be involved in the pathogenesis of these entities [42]. Thus, it is possible that CHIKV-induced arthralgia does not depend on TNF-alpha. Alternatively, TNF-alpha might be produced only locally. Analysis of synovial fluid or joint tissue immunohistochemistry would be necessary to provide important information on the role of TNF-alpha and other mediators.
###end p 39
###begin p 40
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Rot1">[43]</xref>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Qin1">[35]</xref>
Chemokines are crucial mediators of innate and adaptive immunity against various viral infections [43]. IP-10, and MIG had increased plasma levels during CHIKV infection. These two chemokines signal through the same receptor CXCR3 and thus might activate and direct migration of this T cell subset [35]. IL-8 and Eotaxin levels were lower than those of naive controls. Defining the exact contributions of these different chemokines will require further studies.
###end p 40
###begin p 41
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Oka1">[44]</xref>
###xml 78 86 <span type="species:ncbi:9606">patients</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
We also tested the presence of growth factors in the plasma of CHIKV-infected patients. HGF, FGF-basic and VEGF were produced at high levels and may reflect a physiological response to tissue destruction resulting for the viral infection. Interestingly, EGF levels were lower than in healthy controls. The low levels of EGF might be due to the concomitant decrease of platelets observed in infected patients since previous studies have shown that plasma levels of EGF are associated with circulating platelets [44].
###end p 41
###begin p 42
###xml 247 248 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 415 424 406 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004261-g003">Figure 3b</xref>
###xml 539 543 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Wong1">[45]</xref>
###xml 544 548 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee2">[48]</xref>
###xml 871 875 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Dinarello1">[49]</xref>
###xml 1053 1057 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Ellis1">[50]</xref>
###xml 1362 1366 1344 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-John1">[51]</xref>
###xml 1463 1467 1445 1449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Lee2">[48]</xref>
###xml 1508 1512 1490 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Prez1">[52]</xref>
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 498 506 <span type="species:ncbi:9606">patients</span>
###xml 971 979 <span type="species:ncbi:9606">patients</span>
Although limited, we had access to sufficient patients to perform data analysis in relation to the severity of the disease (severe illness was defined as fever >38.5degreesC, or maximum pulse rate >100 beats/minute, or nadir platelet count <100x109/L). Using this definition, we observed that higher disease severity was associated with increased plasma levels of IL-1beta and IL-6 and a decreased level in RANTES (Figure 3b). IL-1beta and IL-6, whose levels are already high in the CHIKV infected patients, are potent endogenous pyrogens [45]-[48]. Therefore, elevations of IL-1beta and IL-6 might account for the high fever in the severe cases. The increase production of IL-1beta might also mediate the development of abrupt and persistent arthralgia since this cytokine is involved in the immunopathogenesis of many arthritic pathologies such as rheumatoid arthritis [49]. On the contrary, T cell chemokine RANTES levels were significantly suppressed in severe CHIKF patients. Platelets are a major reservoir of RANTES in the peripheral circulation [50], and severe CHIKF was characterized by thrombocytopenia. Thus, as mentioned above for EGF, thrombocytopenia can also reduce levels of circulating RANTES. Low levels of RANTES correlate with disease severity and mortality in individuals with severe malaria, who were also correspondingly thrombocytopenic [51]. Interestingly, it was observed in other studies that RANTES levels were up-regulated in dengue [48], except for one single report from Cuba [52]. Since the symptoms of CHIKF mimic those of dengue fever, results obtained from this study strongly suggest that RANTES could be a potential biomarker that differentiates between these 2 clinically very similar diseases.
###end p 42
###begin p 43
###xml 386 390 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Bone1">[24]</xref>
###xml 444 445 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 534 538 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Levi1">[25]</xref>
###xml 591 595 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-BrunBuisson1">[26]</xref>
###xml 597 601 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Vanderschueren1">[27]</xref>
###xml 713 714 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 793 797 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-AIRD1">[28]</xref>
###xml 924 927 918 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Pialoux1">[8]</xref>
###xml 968 972 962 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Economopoulou1">[17]</xref>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 177 185 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 1755 1763 <span type="species:ncbi:9606">patients</span>
One limitation of this study is in the classification of disease severity as none of our patients developed neurologic or hemorrhagic complications previously reported in CHIKF patients. Nonetheless, our definition of severe illness would have included patients with sepsis, a serious form of infection commonly associated with a temperature of >38degreesC and heart rate of >90/minute [24]. Furthermore, we included thrombocytopenia of <100x109/L as a criteria for severe CHIKF. Marked thrombocytopenia is a common feature of sepsis [25] and has been identified as a predictor of mortality [26], [27]. The degree of thrombocytopenia is a determinant of survival and once the platelet count decreases below 100x109/L, mortality continues to increase, even though the risk of bleeding does not [28]. A wide spectrum of disease has been reported in CHIKF ranging from asymptomatic infections, to self-limiting febrile illness [8], to neurologic complications, and death [17]. The "severe illness" cohort in our study possibly represents a more severe form of self-limiting febrile illness, an intermediate group with higher levels of viremia (data not shown) and distinctly more severe clinical features (i.e. high temperature, tachycardia, and severe thrombocytopenia). Using this clinical phenotype, we have shown in this study that immune mediators are able to distinguish very mild disease from more severe forms of CHIKF disease at the acute stage. Follow-up studies will be required to determine if long-term sequelae are indeed different between non-severe and severe clinical presentations. Elucidating the association of disease severity with two cytokines and one chemokine can be useful in order to provide early identification and monitoring of patients with severe disease. Although this study is limited by the size of the outbreak, nevertheless, based on these observations, measurement of immune mediators could be helpful for the management of future outbreaks. This study strongly suggests these biomarkers be used for measuring disease severity and be tested in outbreaks in different populations and different strains. Once confirmed, they will be useful for follow-up studies, association studies, and prognosis for public health management. More importantly, these biomarkers can potentially lead to the development of modulators to reduce disease severity and to halt disease progression.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and Clinical Samples
###end title 45
###begin p 46
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Hasebe1">[53]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Wang1">[54]</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 641 648 <span type="species:ncbi:9606">patient</span>
Ten patients who presented with acute CHIKF to the Communicable Disease Centre at Tan Tock Seng Hospital (CDC/TTSH), the national infectious disease referral centre in Singapore, during the outbreak period from January to February 2008, were included in this study. An acute case of CHIKF was defined as any case with clinical features consistent with CHIKF, and had CHIKV infection confirmed by either reverse transcription-polymerase chain reaction (RT-PCR) or virus isolation [53], [54]. The study was approved by the institution's domain-specific ethics review board (DSRB Reference No. B/08/026). Written consent was obtained from each patient and healthy control subject.
###end p 46
###begin p 47
###xml 791 792 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
###xml 579 586 <span type="species:ncbi:9606">patient</span>
Plasma samples were obtained from patients during the acute phase of their illness. Data on demographic characteristics, pre-morbid conditions, clinical features, and routine hematological and biochemical laboratory test findings (i.e. full blood count, renal and liver function tests, C-reactive protein) were also collected. All symptomatic patients were isolated at CDC/TTSH until the febrile illness resolved and a negative CHIKV RT-PCR test was obtained. During the hospital stay, daily monitoring of body temperature, vital parameters, and blood counts were carried out. A patient was defined as having severe illness, if he had either a maximum temperature of more than 38.5degreesC, or a maximum pulse rate of more than 100 beats/minute, or a nadir platelet count of less than 100x109/L. Laboratory results were expressed as mean+/-SD.
###end p 47
###begin p 48
In addition, plasma or serum samples from 9 healthy volunteers (who did not have a febrile illness in the preceding week and were not epidemiologically-linked to the outbreak) were also included as controls in our study.
###end p 48
###begin title 49
Multiplex Microbead Immunoassay
###end title 49
###begin p 50
###xml 343 348 <span type="species:ncbi:9606">Human</span>
Plasma samples collected as described above, were aliquoted and stored at -80degreesC until analyses were done. A multiplex biometric immunoassay, containing fluorescent dyed microspheres conjugated with a monoclonal antibody specific for a target protein, was used for cytokine measurement according to manufacturer's instructions (Biosource Human Cytokine 30-plex Assay, Invitrogen). The following groups of cytokines were: inflammatory (GM-CSF, IL-1beta, IL-1RA, IL-6, IL-8, TNF-alpha); Th1/Th2 (IFN-gamma, IL-2, IL-2R, IL-4, IL-5, IL-10); Cytokine II (IFN-alpha, IL-7, IL-12p40/p70, IL-13, IL-15, IL-17); Chemokines (Eotaxin, IP-10, MCP-1, MIG, MIP-1alpha, MIP-1beta, RANTES); and Growth Factors (EGF, HGF, FGF-basic, G-CSF, VEGF). Briefly, 25 ul of plasma samples were diluted in 1:2 and incubated with antibody coupled beads for 2 h at RT degreesC. Complexes were washed twice with the use of a vacuum manifold before incubation with biotinylated detector antibody for 1 h at RT degreesC. Complexes were then washed twice followed by incubation with Streptavidin-phycoeryrhrin (RPE) for 30 min at RT degreesC. Complexes were washed thrice and incubated with wash buffer for another 3 min before detection in the Luminex 200trade mark instrument. Results were acquired by the IS 2.3 software and the standard curves were plotted through a five-parameter logistic curve setting.
###end p 50
###begin title 51
Algorithms for Data Analyses
###end title 51
###begin p 52
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Caraux1">[55]</xref>
###xml 594 596 594 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">el</sub>
###xml 593 596 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E<sub>el</sub></italic>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-McQuitty1">[56]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004261-Kendall1">[57]</xref>
###xml 1339 1340 1339 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 1364 1365 1364 1365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1368 1369 1368 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1377 1378 1377 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1381 1382 1381 1382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 965 973 <span type="species:ncbi:9606">patients</span>
To compare and analyze the expression profiles across the results, the raw cytokine values were normalized using z-score conversion based on the formula:where  is the raw value to be converted,  is the mean of the population and  is the standard deviation (SD) of the population. The transformed value is denoted by  and exhibits positive value when the raw value is above mean and vice versa. Further, to examine the nuances and correlations masked in the full set of data, the  values are subjected to cluster analysis [55] to yield an ordered NumOfRows.x NumOfCols expression level matrix, Eel. Hierarchical clustering is applied on the columns which represent the myriad of cytokine levels measurements (e.g.) based on McQuitty's or WPGMA method [56] where the distance between a pair of groups A and B is measured using the weighted arithmetic mean of all the pairwise distances between the data points in A and B. The rows which represent the suspected CHIKF patients and healthy individuals are left untouched. Seriation [57] is performed following the clustering approach to re-order the clustered data points using the minimum path length algorithm to minimize the sum of all the distances between adjacent columns.Euclidean distance is used in both the clustering and seriation phases to measure the difference or dissimilarity, d, between data points (x1, y1) and (x2, y2) given by the equation:
###end p 52
###begin title 53
Statistical Analyses
###end title 53
###begin p 54
###xml 177 178 177 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&lt;0.05</italic>
Comparisons between groups were calculated by Mann-Whitney rank sum. Further statistical analyses were done by Kruskal-Wallis test followed by Dunn's multiple comparison tests. P values of <0.05 were considered to be statistically significant.
###end p 54
###begin title 55
Supporting Information
###end title 55
###begin p 56
###xml 168 176 <span type="species:ncbi:9606">patients</span>
Complete profile of the levels (pg/ml) of cytokines, chemokines and growth factors determined by multiplex-bead arrays from blood samples collected from CHIKV-infected patients and healthy control subjects.
###end p 56
###begin p 57
(0.33 MB EPS)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 162 170 <span type="species:ncbi:9606">patients</span>
Box-and-whisker graphs of 14 immune mediators (cytokines and chemokines) determined from blood samples collected from healthy control subjects and CHIKV-infected patients.
###end p 59
###begin p 60
(0.40 MB EPS)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 148 156 <span type="species:ncbi:9606">patients</span>
Box-and-whisker graphs of 13 Chemokines and growth factors determined from blood samples collected from healthy control subjects and CHIKV-infected patients.
###end p 62
###begin p 63
(0.40 MB EPS)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 19 31 <span type="species:ncbi:9606">participants</span>
###xml 96 101 <span type="species:ncbi:94398">Kiang</span>
###xml 416 423 <span type="species:ncbi:9606">patient</span>
###xml 615 622 <span type="species:ncbi:9606">patient</span>
We thank the study participants and healthy volunteers for their participation in the study; Li-Kiang Tan (Environmental Health Institute) for molecular diagnostics; Meng-Li Teo (Communicable Disease Centre/Tan Tock Seng Hospital), for assistance in blood sample preparation; Clement Kan (Communicable Disease Centre/Tan Tock Seng Hospital) and Mar Kyaw Win (Communicable Disease Centre/Tan Tock Seng Hospital), for patient enrollment, study coordination and data entry; medical officer Joanne Kua and the staff of Communicable Disease Centre/Tan Tock Seng Hospital's Specialist Outpatient Clinic J and Ward 83 for patient enrollment and care. We also thank Laurent Renia (Singapore Immunology Network) and Georges Snounou (Singapore Immunology Network) for critically reading the manuscript.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
Tropical disease follows mosquitoes to Europe.
###end article-title 67
###begin article-title 68
How did Chikungunya reach the Indian Ocean?
###end article-title 68
###begin article-title 69
Imported Chikungunya infection, Italy.
###end article-title 69
###begin article-title 70
Etiologies of acute undifferentiated febrile illness in Thailand.
###end article-title 70
###begin article-title 71
Reemergence of endemic Chikungunya, Malaysia.
###end article-title 71
###begin article-title 72
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients.
###end article-title 72
###begin article-title 73
Clinical features and molecular diagnosis of chikungunya fever from South India.
###end article-title 73
###begin article-title 74
Chikungunya, an epidemic arbovirosis.
###end article-title 74
###begin article-title 75
###xml 21 38 <span type="species:ncbi:37124">Chikungunya virus</span>
Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus.
###end article-title 75
###begin article-title 76
Genome microevulotuion of Chikungunya viruses causing the Indian Ocean outbreak.
###end article-title 76
###begin article-title 77
###xml 6 23 <span type="species:ncbi:37124">Chikungunya virus</span>
Novel Chikungunya virus variant in travelers returning from Indian Ocean islands.
###end article-title 77
###begin article-title 78
###xml 0 16 <span type="species:ncbi:7160">Aedes albopictus</span>
###xml 42 59 <span type="species:ncbi:37124">Chikungunya virus</span>
Aedes albopictus as an epidemic vector of Chikungunya virus: another emerging problem?
###end article-title 78
###begin article-title 79
Chikungunya outbreaks-the globalization of vectorborne diseases.
###end article-title 79
###begin article-title 80
East Central South African genotype as the causative agent in re-emergence of Chikungunya outbreak in India.
###end article-title 80
###begin article-title 81
The Chikungunya threat: an ecological and evolutionary perspective.
###end article-title 81
###begin article-title 82
Alphavirus: an emerging cause of arthritis?
###end article-title 82
###begin article-title 83
###xml 9 26 <span type="species:ncbi:37124">chikungunya virus</span>
Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease duing the 2005-2006 outbreak on Reunion.
###end article-title 83
###begin article-title 84
Chikungunya fever in travellers: clinical presentations and course.
###end article-title 84
###begin article-title 85
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model for Chikungunya: young and age and inefficient type 1 interferon signaling are risk factors for severe disease.
###end article-title 85
###begin article-title 86
###xml 49 66 <span type="species:ncbi:37124">Chikungunya virus</span>
An animal model for studying the pathogenesis of Chikungunya virus infection.
###end article-title 86
###begin article-title 87
Chikungunya fever, Hong Kong.
###end article-title 87
###begin article-title 88
Chikungunya Fever Cases Detected At Clive Street.
###end article-title 88
###begin article-title 89
Update on Chikungunya Fever Cases (5).
###end article-title 89
###begin article-title 90
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.
###end article-title 90
###begin article-title 91
Platelets at a crossroad of pathogenic pathways in sepsis.
###end article-title 91
###begin article-title 92
French ICU Group for Severe Sepsis. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units.
###end article-title 92
###begin article-title 93
Thrombocytopenia and prognosis in intensive care.
###end article-title 93
###begin article-title 94
The Hematologic System as a Marker of Organ Dysfunction in Sepsis.
###end article-title 94
###begin article-title 95
Chikungunya (07): Singapore.
###end article-title 95
###begin article-title 96
###xml 15 32 <span type="species:ncbi:37124">chikungunya virus</span>
Infection with chikungunya virus in Italy: an outbreak in a temperate region.
###end article-title 96
###begin article-title 97
###xml 49 54 <span type="species:ncbi:9606">child</span>
###xml 55 72 <span type="species:ncbi:37124">Chikungunya virus</span>
Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion.
###end article-title 97
###begin article-title 98
###xml 31 48 <span type="species:ncbi:37124">Chikungunya virus</span>
Characterization of reemerging Chikungunya virus.
###end article-title 98
###begin article-title 99
IPC: Professional Type I Interferon-producing cells and plasmacytoid dendritic cell precursors.
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human monocytes represent a competitive source of interferon-alpha in peripheral blood.
###end article-title 100
###begin article-title 101
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
###end article-title 101
###begin article-title 102
###xml 55 60 <span type="species:ncbi:9606">human</span>
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
###end article-title 102
###begin article-title 103
IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2.
###end article-title 103
###begin article-title 104
###xml 60 65 <span type="species:ncbi:9606">human</span>
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
###end article-title 104
###begin article-title 105
Interleukin-7 in rheumatoid arthritis.
###end article-title 105
###begin article-title 106
Emerging cytokine targets in rheumatoid arthritis.
###end article-title 106
###begin article-title 107
A subset of natural killer cells is greatly expanded within inflamed joints.
###end article-title 107
###begin article-title 108
Cytokine production in the rheumatoid joint: implications for treatment.
###end article-title 108
###begin article-title 109
Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.
###end article-title 109
###begin article-title 110
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
###end article-title 110
###begin article-title 111
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.
###end article-title 111
###begin article-title 112
Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.
###end article-title 112
###begin article-title 113
###xml 59 71 <span type="species:ncbi:12637">dengue virus</span>
Systemic host inflammatory and coagulation response in the dengue virus primo-infection.
###end article-title 113
###begin article-title 114
###xml 26 31 <span type="species:ncbi:9606">human</span>
Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES.
###end article-title 114
###begin article-title 115
Biologic basis for interleukin-1 in disease.
###end article-title 115
###begin article-title 116
###xml 43 51 <span type="species:ncbi:9606">patients</span>
Significance of the CC chemokine RANTES in patients with haematological malignancy: results from a prospective observational study.
###end article-title 116
###begin article-title 117
###xml 54 62 <span type="species:ncbi:9606">children</span>
Low levels of RANTES are associated with mortality in children with cerebral malaria.
###end article-title 117
###begin article-title 118
###xml 23 31 <span type="species:ncbi:9606">patients</span>
IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba.
###end article-title 118
###begin article-title 119
###xml 37 54 <span type="species:ncbi:37124">Chikungunya virus</span>
Combined detection and genotyping of Chikungunya virus by a specific reverse transcription-polymerase chain reaction.
###end article-title 119
###begin article-title 120
Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections.
###end article-title 120
###begin article-title 121
Permutmatrix: a graphical environment to arrange gene expression profiles in optimal linear order.
###end article-title 121
###begin article-title 122
Similarity analysis by reciprocal pairs for discrete and continuous data.
###end article-title 122
###begin article-title 123
Seriation.
###end article-title 123
###begin p 124
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 124
###begin p 125
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by core grants provided by the Singapore Immunology Network, Biomedical Research Council at the Agency for Science, Technology and Research (A*STAR); and the Communicable Disease Centre, Tan Tock Seng Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 125

